OVERVIEW TARGETED DRUG DELIVERY
Patients report a reduction in pain scores after receiving targeted drug delivery.
- 51% of patients completely eliminated other opioids* at 12 months.1
- 87% of patients rated their quality of life as fair to excellent.2
- 90% of patients would recommend therapy to a family member or friend.2
PAIN RELIEF
Discover how the SynchroMed™ II pump and myPTM™ Personal Therapy Manager deliver pain relief.
FIND OUT MORESPEAK WITH AN EXPERT
We’ll help you get the answers you need to determine if this therapy is right for you. Chat with a current patient (Ambassador) or nurse, or find a physician in your area.
FIND AN EXPERTOUR STRENGTH IS OUR
MEDTRONIC IS A WORLDWIDE LEADER
Over 30 years of experience in targeted drug delivery3
More than 300,000 SynchroMed II pumps implanted worldwide4
THE WIDEST PHYSICIAN NETWORK AVAILABLE
We have helped patients in more than 120 countries. Find a physician in the United States who can help you learn more.
FIND A PHYSICIAN
*
Other opioids include systemic opioids.
†
Under specific conditions. Talk to your doctor and refer to product labeling for full list of conditions.
1
Hatheway JA, et al. Systemic opioid elimination after implantation of an intrathecal drug delivery system significantly reduced health-care expenditures. Neuromodulation. 2015 Apr;18(3):207-13.
2
Deer T, Chapple I, Classen A, et al. Intrathecal drug delivery for treatment of chronic low back pain; report from the National Outcomes Registry for Low Back Pain. Pain Med. 2004;5(1):6-13.
3
Medtronic data on file.
4
Medtronic data on file.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.